These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16741523)

  • 1. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
    Zlobec I; Steele R; Michel RP; Compton CC; Lugli A; Jass JR
    Mod Pathol; 2006 Sep; 19(9):1236-42. PubMed ID: 16741523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
    Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
    Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
    Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.
    Zlobec I; Steele R; Nigam N; Compton CC
    Clin Cancer Res; 2005 Aug; 11(15):5440-3. PubMed ID: 16061859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Manne U; Myers RB; Srivastava S; Grizzle WE
    J Natl Cancer Inst; 1997 Apr; 89(8):585-6. PubMed ID: 9106651
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.
    Perrone G; Vincenzi B; Santini D; Verzì A; Tonini G; Vetrani A; Rabitti C
    Cancer Lett; 2004 May; 208(2):227-34. PubMed ID: 15142682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
    Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
    Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic markers for colorectal cancer: expression of P53 and BCL2.
    Pereira H; Silva S; Julião R; Garcia P; Perpétua F
    World J Surg; 1997 Feb; 21(2):210-3. PubMed ID: 8995081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
    Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
    World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
    Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
    Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
    Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
    Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
    Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
    Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?
    Funaioli C; Pinto C; Mutri V; Di Fabio F; Ceccarelli C; Martoni AA
    Clin Colorectal Cancer; 2006 May; 6(1):38-45. PubMed ID: 16796790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.